With 4.49% Distance From Low, Is AVITA Medical Inc (NASDAQ:RCEL) Poised For More Gains?

In last trading session, AVITA Medical Inc (NASDAQ:RCEL) saw 0.3 million shares changing hands with its beta currently measuring 1.57. Company’s recent per share price level of $6.46 trading at $0.09 or 1.41% at ring of the bell on the day assigns it a market valuation of $160.47M. That closing price of RCEL’s stock is at a discount of -119.2% from its 52-week high price of $14.16 and is indicating a premium of 4.49% from its 52-week low price of $6.17. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.43 million shares which gives us an average trading volume of 234.19K if we extend that period to 3-months.

For AVITA Medical Inc (RCEL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.88. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

AVITA Medical Inc (NASDAQ:RCEL) trade information

Upright in the green during last session for gaining 1.41%, in the last five days RCEL remained trading in the red while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $6.46 price level, adding 13.06% to its value on the day. AVITA Medical Inc’s shares saw a change of -49.53% in year-to-date performance and have moved -7.32% in past 5-day. AVITA Medical Inc (NASDAQ:RCEL) showed a performance of -28.38% in past 30-days. Number of shares sold short was 2.97 million shares which calculate 15.54 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 53.86% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -116.72% in reaching the projected high whereas dropping to the targeted low would mean a loss of -116.72% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -88.92% during past 5 years.

AVITA Medical Inc (NASDAQ:RCEL)’s Major holders

Insiders are in possession of 0.82% of company’s total shares while institution are holding 26.81 percent of that, with stock having share float percentage of 27.03%. Investors also watch the number of corporate investors in a company very closely, which is 26.81% institutions for AVITA Medical Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at RCEL for having 1.78 million shares of worth $14.13 million. And as of 2024-06-30, it was holding 7.0222 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.4 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.4945 of outstanding shares, having a total worth of $11.05 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 800.72 shares of worth $5.17 million or 3.03% of the total outstanding shares. The later fund manager was in possession of 669.39 shares on Mar 31, 2025 , making its stake of worth around $4.32 million in the company or a holder of 2.53% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.